Helga Sanner
Position: MD, PhD
Phone: +47 23 07 33 23
Email:
Research topics; Juvenile dermatomyositis,
 

Author network for Helga Sanner by COREMINE medical


Publications 2016

Schwartz T, Diederichsen LP, Lundberg IE, Sjaastad I, Sanner H (2016)
Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies
RMD Open, 2 (2), e000291
PubMed 27752355

Publications 2015

Barth Z, Nomeland Witczak B, Schwartz T, Gjesdal K, Flatø B, Koller A, Sanner H, Sjaastad I (2015)
In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset
Rheumatology (Oxford), 55 (3), 535-43
PubMed 26500284

Publications 2014

Lilleby V, Haydon J, Sanner H, Krossness BK, Ringstad G, Flatø B (2014)
Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis
Scand J Rheumatol, 43 (2), 171-3
PubMed 24588361

Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H et al. (2014)
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients
Arthritis Rheumatol, 66 (11), 3160-9
PubMed 25077692

Sanner H, Schwartz T, Flatø B, Vistnes M, Christensen G, Sjaastad I (2014)
Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage
PLoS One, 9 (3), e92171
PubMed 24647150

Sanner H, Sjaastad I, Flatø B (2014)
Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool
Rheumatology (Oxford), 53 (9), 1578-85
PubMed 24692575

Schwartz T, Sjaastad I, Flatø B, Vistnes M, Christensen G, Sanner H (2014)
In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction
Rheumatology (Oxford), 53 (12), 2214-22
PubMed 24996906

Publications 2013

Schwartz T, Sanner H, Gjesdal O, Flatø B, Sjaastad I (2013)
In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity
Ann Rheum Dis, 73 (10), 1805-10
PubMed 23881732

Publications 2012

Tollisen A, Sanner H, Flatø B, Wahl AK (2012)
Quality of life in adults with juvenile-onset dermatomyositis: a case-control study
Arthritis Care Res (Hoboken), 64 (7), 1020-7
PubMed 22328537

Publications 2011

Schwartz T, Sanner H, Husebye T, Flatø B, Sjaastad I (2011)
Cardiac dysfunction in juvenile dermatomyositis: a case-control study
Ann Rheum Dis, 70 (5), 766-71
PubMed 21216816

Publications 2010

Sanner H, Kirkhus E, Merckoll E, Tollisen A, Røisland M, Lie BA, Taraldsrud E, Gran JT, Flatø B (2010)
Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case-control study
Arthritis Care Res (Hoboken), 62 (8), 1103-11
PubMed 20506141

Sanner H, Aaløkken TM, Gran JT, Sjaastad I, Johansen B, Flatø B (2010)
Pulmonary outcome in juvenile dermatomyositis: a case-control study
Ann Rheum Dis, 70 (1), 86-91
PubMed 20805295

Publications 2009

Sanner H, Gran JT, Sjaastad I, Flatø B (2009)
Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset
Rheumatology (Oxford), 48 (12), 1541-7
PubMed 19776224